Knowledge Center

Resources & FAQ

Everything you need to understand, deploy, and support Bridge IV wellness products. Download brochures, watch training videos, and find answers to common questions.

Downloadable Resources

Product Brochures & Materials

Access comprehensive product documentation, training materials, and logistics guides. All resources are available as downloadable PDFs.

Fleboflex Container Brochure

Complete product overview of the Fleboflex polypropylene IV container system, specifications, and clinical advantages.

Download PDF

Fleboflex Luer Brochure

Detailed specifications for the Fleboflex Luer connector system, compatibility data, and ordering information.

Download PDF

Fleboflex & Fleboflex Luer Combined Brochure

Side-by-side comparison of both container systems with use-case guidance for clinic operators.

Download PDF

Anticoagulant Sodium Citrate 4% Brochure

Product specifications, approved indications, safety information, and storage requirements for Sodium Citrate 4%.

Download PDF

Delivery & Logistics Information

Shipping protocols, temperature-controlled distribution details, and same-day fulfillment capabilities.

Download PDF

Fleboflex Luer E-Learning Course

Interactive training module covering proper handling, administration technique, and best practices for Fleboflex Luer.

Download PDF

Fleboflex Storage Information Flyer

Temperature guidelines, shelf-life data, and recommended storage conditions for maintaining product integrity.

Download PDF

Training Videos

Product Training & Demonstrations

Watch detailed product overviews and training modules to ensure your team is fully prepared for safe, effective IV administration.

February 2024

Product Overview: 0.9% Sodium Chloride in Fleboflex Container

Learn about the Fleboflex container system for 0.9% Sodium Chloride Injection, USP -- features, handling, and clinical applications.

February 2024

Product Overview: 0.9% Sodium Chloride in Fleboflex Luer Container

Detailed walkthrough of the Fleboflex Luer container, its luer-lock connection system, and administration protocols.

February 2024

Fleboflex Luer with CSTD Compatibility

Technical demonstration of 0.9% Sodium Chloride in Fleboflex Luer when used with Closed System Transfer Devices (CSTDs).

Frequently Asked Questions

Common Questions

Answers to the most common technical and clinical questions about our IV solutions and container systems.

Which drugs are compatible with the Fleboflex and Fleboflex Luer containers?

The Fleboflex bag has drug-container compatibility studies with a select number of medications. Bridge provides compatibility tables between drugs and containers in the downloadable brochures above. Contact our team for specific compatibility inquiries.

What is the advantage of polypropylene compared to PVC?

Polypropylene offers greater drug compatibility compared to PVC containers. It is free of DEHP and other plasticizers, reducing the risk of leaching. This makes it the preferred choice for pharmaceutical-grade IV solutions across clinical settings.

Do Fleboflex or Fleboflex Luer contain latex?

No. All products distributed through Bridge are latex-free, meeting the highest safety standards for patients with latex sensitivities.

Does Fleboflex have guaranteed tempered distribution with temperature control?

Yes. In the US, 0.9% Sodium Chloride solution in the Fleboflex container is transported under controlled conditions between +2°C and +25°C. All transport is carried out in qualified vehicles with continuous temperature monitoring to ensure product integrity from warehouse to clinic.

Can Fleboflex and Fleboflex Luer bags be labeled with markers?

No. Labeling plastic containers (PE, PVC, or PP) with markers is not recommended because the inks contain volatile solvents that could enter the interior of the container and compromise sterility. Use approved labeling systems only.

Can Sodium Citrate 4% be used for intravenous infusion?

No. Sodium Citrate 4% CANNOT be used for direct intravenous infusion. It is indicated only for approved anticoagulant applications. Refer to the product brochure for complete prescribing information and approved indications.

Reference: Cohen MR, ed. Chapter 7. The role of drug packaging and labeling in medication errors. Medication errors. 2nd edition. American Pharmacists Association; 2007:111-152.

Have a question not listed here?

Our team is ready to help with product inquiries, compatibility questions, training requests, or custom logistics needs.